RMD
ResMed Inc.
Surgical & Medical Instruments & Apparatus- 売上
- $5.1bn
- 時価総額
- $30.6bn
株価 $208.56 · 100株 2万円
| 期 | 23/06 | 24/06 | 25/06 |
|---|---|---|---|
| 売上 | $4.2bn | $4.7bn | $5.1bn |
| 成長率 | — | 10.9% | 9.8% |
| 総利益 | $2.4bn | $2.7bn | $3.1bn |
| 総利益率 | 55.8% | 56.7% | 59.4% |
| 販管費 | $874m | $917m | $991m |
| 販管費率 | 20.7% | 19.6% | 19.3% |
| 営利 | $1.1bn | $1.3bn | $1.7bn |
| 営利率 | 26.8% | 28.2% | 32.7% |
| 純利益 | $898m | $1.0bn | $1.4bn |
| PBR | 7.4 | 6.3 | 5.1 |
| PSR | 7.3 | 6.5 | 6.0 |
| PGPR | 13.0 | 11.5 | 10.0 |
| PER | 34 | 30 | 22 |
| ﾈｯﾄｷｬｯｼｭ | ▲$1.2bn | ▲$469m | $541m |
| EV/EBITDA | 24.6 | 20.8 | 16.0 |
| Rule of 40 | — | 39% | 43% |
| セールス効率 | — | 695% | 541% |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）